Phase I study of Ibrutinib and the CXCR4 antagonist Ulocuplumab in CXCR4 mutated Waldenstrom Macroglobulinemia.
暂无分享，去创建一个
S. Treon | A. Roccaro | A. Sacco | I. Ghobrial | Z. Hunter | A. Branagan | J. Castillo | S. Sarosiek | Guang Yang | Lian Xu | Yanglin Cao | K. Meid | C. Patterson | Xia Liu | Manit Munshi | Amanda Kofides | M. Demos | M. L. Guerrera | Catherine A. Flynn | Carly Leventoff | Timothy P. White | N. Tsakmaklis